(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals

National Pharmaceutical Pricing Authority

New Delhi, the 22nd January, 2016

ORDER

S.O. 217(E)- In exercise of the powers, conferred by paragraph 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby withdraw the Gazette Notifcation S.O. No. 1892(E) dated 13th July, 2015, relating to retail price fixation of Clopidogrel + Atorvastatin + Aspirin Capsule (Deplatt CV 20 Forte) for 1 Capsule, manufactured by M/s Surein Pharmaceuticals Pvt. Ltd. and Marketed by M/s Torrent Pharmaceuticals Ltd, with immediate effect.

PN/158/26/2016/F

F. No. 8(26)/2016/D.P./NPPA-Div.-II
(ANAND PRAKASH)
Deputy Director